Pharmacogenetics of immunosuppressants: State of the art and clinical implementation – recommendations from the French National Network of Pharmacogenetics (RNPGx)-Reference-Cited by-同舟云学术

Pharmacogenetics of immunosuppressants: State of the art and clinical implementation – recommendations from the French National Network of Pharmacogenetics (RNPGx)

Published:2017-04 Issue:2 Volume:72 Page:285-299
ISSN:0040-5957
Container-title:Therapies
language:en
Short-container-title:Therapies

Author:

Woillard Jean-Baptiste,Chouchana Laurent,Picard Nicolas,Loriot Marie-Anne

Publisher

Elsevier BV

Subject

Pharmacology (medical)

Reference132 articles.

1. Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs;Kronbach;Clin Pharmacol Ther,1988

2. FK 506 metabolism in human liver microsomes: investigation of the involvement of cytochrome P450 isozymes other than CYP3A4;Karanam;Drug Metab Dispos Biol Fate Chem,1994

3. Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat;Sattler;Drug Metab Dispos Biol Fate Chem,1992

4. Clinical pharmacokinetics of everolimus;Kirchner;Clin Pharmacokinet,2004

5. CYP3A5. 2013. http://www.cypalleles.ki.se/cyp3a5.htm.2013. [accessed 19 October 2016].

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP3A5 and POR gene polymorphisms as predictors of infection and graft rejection in post-liver transplant patients treated with tacrolimus - a cohort study;2023-10-09

2. Pharmacogenetics of 6-mercaptopurine in a black Zimbabwean cohort treated for acute lymphoblastic leukaemia;Pharmacogenomics;2023-06

3. PAnno: A pharmacogenomics annotation tool for clinical genomic testing;Frontiers in Pharmacology;2023-01-26

4. Influence of CYP3A5, IL-10 polymorphisms and metabolism rate on tacrolimus exposure in renal post-transplant recipients;Pharmacogenomics;2022-12

5. Pharmacogenes that demonstrate high association evidence according to CPIC, DPWG, and PharmGKB;Frontiers in Medicine;2022-10-25